Back | Next |
home / stock / ckpt / ckpt message board
Subject | By | Source | When |
---|---|---|---|
Im stating to wish I added after the | vein | investorshub | 01/04/2023 2:10:23 PM |
There is the BLA | vein | investorshub | 01/04/2023 1:09:42 PM |
wow, just got back home, nice gain! | Monroe1 | investorshub | 01/04/2023 1:03:13 AM |
Sure seems that way. I should have | chainma1l | investorshub | 01/03/2023 9:27:30 PM |
BLA on the way ?? | vein | investorshub | 01/03/2023 3:58:50 PM |
2023 | vein | investorshub | 12/31/2022 3:38:29 AM |
I don't expect to be around in 3023, | dtgsanjose | investorshub | 12/31/2022 3:10:56 AM |
Anyone think we can look forward to recovery | vein | investorshub | 12/30/2022 4:21:23 PM |
Maybe that's why they lowered the AS | Monroe1 | investorshub | 12/17/2022 12:20:29 AM |
Might be something to get excited about | vein | investorshub | 12/15/2022 6:54:34 PM |
It seems the BLA is coming soon !! | vein | investorshub | 12/15/2022 2:22:45 PM |
Yeah true !! | vein | investorshub | 12/15/2022 2:22:12 PM |
$7.5 million isn't much money (in the grand | chainma1l | investorshub | 12/15/2022 2:07:37 PM |
Still alive. Good sign. | Monroe1 | investorshub | 12/15/2022 2:01:10 PM |
Raising cash | vein | investorshub | 12/15/2022 1:26:14 PM |
Most have, I think so too. The month | Monroe1 | investorshub | 12/09/2022 2:15:18 PM |
The float is painfully low for sure . | vein | investorshub | 12/08/2022 10:58:07 PM |
Hopefully that doesn't actually come to pass. | chainma1l | investorshub | 12/08/2022 10:42:58 PM |
You would think most of the losses are incurred!!! | vein | investorshub | 12/08/2022 10:40:35 PM |
Tax loss selling ... not seen the end | Monroe1 | investorshub | 12/08/2022 10:17:03 PM |
News, Short Squeeze, Breakout and More Instantly...
Checkpoint Therapeutics Inc. Company Name:
CKPT Stock Symbol:
NASDAQ Market:
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy and ...
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in a fireside chat...
WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the first quarter ended March 31, 2024, and recent corporate updates. ...